Suspended

Warm Compress Therapy for Postoperative Dry Eye in Cataract Surgery

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Warm Compress

+ Standard Care

Combination ProductDiagnostic Test
Who is being recruted

Eye Diseases

+ Lacrimal Apparatus Diseases

+ Dry Eye Syndromes

From 50 to 70 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: March 2025
See protocol details

Summary

Principal SponsorSuperior University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 20, 2025

Actual date on which the first participant was enrolled.

This study focuses on testing whether using warm compresses can help improve the stability of tears and lessen dry eye symptoms in people who have undergone cataract surgery. It targets individuals aged 50 to 70 who already experience moderate to severe dry eye issues, which are often worsened after such surgeries. By potentially providing a simple, non-invasive solution to enhance tear film quality, this study could significantly improve comfort and eye health for patients dealing with post-surgery dry eye syndrome. Participants in this study are divided into two groups. One group receives warm compress therapy before and after their cataract surgery, while the other group continues with the usual treatments for dry eyes over a period of six weeks. This approach allows researchers to compare the effectiveness of warm compresses against standard treatments in reducing symptoms and improving eye moisture stability. The results will be measured by evaluating changes in tear film stability and dry eye symptoms, providing insight into the benefits of warm compress therapy for these patients.

Official TitleEfficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative Dry Eye Syndrome After Cataract Surgery: A Randomized Controlled Trial
NCT06914232
Principal SponsorSuperior University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

54 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 50 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesLacrimal Apparatus DiseasesDry Eye Syndromes

Criteria

3 inclusion criteria required to participate
Patients aged 30 to 70 years
Patients scheduled for cataract surgery (both unilateral and bilateral).
Patients with preoperative moderate to severe dry eye symptoms, which will be assessed using the Ocular Surface Disease Index (OSDI).
6 exclusion criteria prevent from participating
Patients with OSDI, indicating severe dry eye disease which suggests severe dry eye disease. These patients might require more intensive treatments beyond Warm Compress therapy.
Patients with systemic diseases (e.g., rheumatoid arthritis, lupus) that affect tear production or who are using medications that severely reduce tear production (e.g., chronic use of antihistamines or systemic corticosteroids).
Patients with significant pre-existing corneal pathology (e.g., corneal dystrophies, corneal scars) that could affect the results of cataract surgery or thermal pulsation therapy.
Patients with active ocular infections (e.g., conjunctivitis, keratitis) or inflammation at the time of screening or surgery.
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Group II

Active Comparator

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Hakeem mahmood trust hospital address alam chowk mean baipas

Gujranwala, PakistanOpen Hakeem mahmood trust hospital address alam chowk mean baipas in Google Maps
SuspendedOne Study Center